Vantagetrade – The Agen Poker major indexes held gains in afternoon trading Wednesday, with the S&P 500 making a notable move on its chart.
OffThe S&P 500 climbed 0.4% and held up at its 50-day moving average. That suggests the S&P is withstanding Tuesday’s sell-off. The Nasdaq composite added 0.3% and has floated above the 50-day line for about a week now. Both were near session highs around 3 p.m. ET.
The small-cap Russell 2000 rose 0.4% also while the Agen Poker utilities average lost 0.6%. A July-August rally in the utilities gauge has been cooling off for about a week. The Dow Jones industrial average added 0.3%. Volume on both exchanges was tracking lower compared with the same time Tuesday.
On the losing side, GoDaddy (GDDY) lost 3% after the internet domain-name registrar and website-hosting firm announced a new share offering by private equity firms that control the company. The stock has been enigmatic, breaking out Aug. 9 but falling back into its pattern right away and triggering a sell signal. GoDaddy may be basing again.
Dave & Buster’s (PLAY) plunged 10.5% in huge volume after the restaurant chain beat profit estimates for the July-ended quarter but cut its full-year same-store sales estimates. The arcade-style restaurant company missed sales expectations and its same-store sales rise of 1.1% was well short of views.Indexes showed a slight uptick after the Federal Reserve released its Beige Book survey of economic conditions around the nation. The report noted continued moderate growth but worker shortages, especially in manufacturing and construction. Also Read : A complete model profile leads to the Gig Economy
Agen Poker remain an area of strength, still ranked in the top 10 of 197 industry groups ranked by IBD based on six-month price performance. Two companies in the group made bullish advances.
Sarepta Therapeutics (SRPT) broke out of a cup-without-handle base following encouraging trial results for a potential treatment for Agen Poker muscular dystrophy. Investors saw the early and mid-stage trial as a sign that the drug may win accelerated approval. The Cambridge, Mass.-based company’s shares gapped past a 44.34 buy point in strong volume.
Molecular diagnostics firm Exact Sciences (EXAS) topped the 42.28 buy point of a flat base. But volume was light, making the breakout suspect. The company presented today at the Baird Global Healthcare Conference. The stock sank to the lowest level since Dec. 6, and worsened a price decline that has been unfolding since a peak in early June.
CME Group (CME) edged above the 128.06 entry of a flat base. On Tuesday, the operator of the Chicago Mercantile Exchange and other financial exchanges said average daily volume in August reached 16 million contracts, up 16% from a year ago.